Pharmaceutical Development & Manufacturing
-
Innovation In Bayer HealthCare’s Quality Management
2/27/2015
“Innovation” and “pharmaceutical quality management” inhabit the same sentence more often these days. Bayer HealthCare’s Director of Quality Assurance for Biologic Product Development in Berkeley, Dr. Claudia Lin, takes pride in that.
-
Is China Casting Shadows On Other Opportunities In Asia Pacific?
2/27/2015
Some came looking for a prevailing regional paradigm to hang a hat on, others for specific country advantages and market idiosyncrasies, and maybe most of all, insight into selecting partners and service providers.
-
The R&D Tax Credit — A Catalyst For Life Sciences Innovation
2/25/2015
Does your company develop new medical products, pharmaceuticals, or innovative production techniques in the United States?
-
Cubist: The Curtain Closes
2/25/2015
The company's chief scientist recounts the lessons learned by this leader in antibiotics, up to its merger with Merck.
-
Ever Notice How Q1 In Biopharma Provides A Study In Contrasts?
2/25/2015
The first quarter in the life sciences industry provides a wonderful study in contrasts. For example, in January at the 33rd Annual J.P. Morgan (JPM) Healthcare Conference, some of the largest pharmaceutical and biotech companies conduct presentations to packed rooms at the Westin St. Francis.
-
Creating A Culture Of Trust And Innovation In Pharma
1/28/2015
There is an urgent need for the pharma industry to redefine itself in the minds of stakeholders following the disappointing business and share price performance of recent years. It is time for the industry to redouble its efforts, and a good place to start is by focusing on culture as the most critical driver of breakthrough innovation and business success.
-
Merck’s Continuous Process Improvement
7/1/2014
Continuous improvement doesn’t just depend upon Lean principles and/or zero-based budgeting. It depends upon people inspired by a culture that values learning, promotes problem-solving skills, and strives toward big goals by making small improvements every day.
-
Millennium Carries On With The Takeda Oncology Expansion
6/30/2014
Since I’ve been writing about the pharma industry for many years, I often find it impossible to walk in any direction without bumping into a connection from the past. It seems like a thousand years ago that I interviewed Millennium’s founder, Mark Levin, soon after the launch of its hallmark cancer drug. Certainly enough has transpired since then.
-
A Tough Lesson On The Road To Commercialization
4/30/2014
How do researchers determine their science is worth taking to translational research and commercialization? Good science alone is not enough. The challenges of funding, competition, and regulatory hurdles crush many endeavors. Entrepreneurs find that commercialization starts with good data but requires developing networks, precise planning, building an experienced team, and perseverance.
-
The Looming Battle Between The Pharmaceutical And Health Plan Industries
4/29/2014
Although generic utilization has never been higher — a new report by the IMS Institute for Healthcare Informatics notes that 86 percent of all prescriptions filled were generic and more than half of prescriptions cost patients on average less than $5 out-of-pocket — the growing cost of specialty medicines is sparking a marketing and policy battle between the pharmaceutical industry and plans that cover those drugs.